A comprehensive study conducted by Meticulous Research®, a prominent market research firm, has released a report titled, ‘U.S. Direct-to-consumer Laboratory Testing Market by Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological, Cardiac]}, Diabetes, Thyroid, STD, Routine, CBC), Sample Type (Saliva, Urine, Blood) - Forecast to 2030.’
As per the latest report by Meticulous Research®, the U.S. direct-to-consumer laboratory testing market is anticipated to achieve a value of $3.91 billion by 2030, with a compounded annual growth rate (CAGR) of 10.4% from 2023 to 2030. The market's expansion is propelled by various factors, including the surge in chronic and sexually transmitted diseases, elevated disposable incomes, heightened consumer awareness, growing emphasis on personal health management, and the advantages offered by direct-to-consumer (DTC) laboratory testing such as convenience, affordability, and accessibility. Additionally, factors like the rising prevalence of chronic and infectious ailments, escalating healthcare costs, increased awareness about ancestry and genealogy testing, a growing elderly population, and rising interest in predictive testing contribute to this growth. Opportunities such as the increased adoption of telehealth, expansion into emerging markets, and the wider use of pharmacogenomic testing in DTC laboratory testing are also expected to foster market growth in the future.
Issues like genetic data privacy worries, potential result misinterpretations, and insufficient medical guidance pose challenges for the U.S. direct-to-consumer laboratory testing market. Conversely, hindrances such as sample integrity and interference problems, regulatory issues, reimbursement gaps, and a narrower test selection compared to traditional lab testing impede market growth.
Key Players
The major players outlined in the report on the U.S. direct-to-consumer laboratory testing market include DirectLabs, LLC (U.S.), MyMedLab, Inc. (U.S.), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), 23andMe Holding Co. (U.S.), EverlyWell, Inc. (U.S.), Ancestry.com, LLC (U.S.), Myriad Genetics, Inc. (U.S.), ANY LAB TEST NOW (U.S.), and LetsGetChecked, Inc. (U.S.).
The U.S. direct-to-consumer laboratory testing market is divided based on Application (including Genetic Testing for Ancestry/Genealogy, Disease/Risk Assessment such as Cancer and Cardiovascular Diseases, Carrier Status, and Other Genetic Tests, along with Diabetes Testing, Routine Clinical Testing, Thyroid Function Testing, Sexually Transmitted Disease Testing, and Other Applications), Sample Type (comprising Blood, Saliva, Urine, and Other Samples), and Geography. The research assesses competitors within the industry and scrutinizes both regional and country-level markets.




Among applications, by 2023, the genetic testing segment is projected to hold the most significant portion of the market. This dominance is credited to the growing interest in direct-to-consumer genetic testing, driven by the desire to uncover family health history and assess disease risks. Additionally, the introduction of new direct-to-consumer genetic tests for various applications and heightened curiosity among individuals in developed nations about their ancestry and heritage contribute to this segment's prominence.
Among sample types, the blood segment is anticipated to hold the largest market share. This is primarily due to the advantages associated with blood samples, including their high result reliability, the extensive array of available test options, and the convenience offered by at-home blood collection services.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5728
Key questions answered in the report-
• Which segments within the direct-to-consumer laboratory testing market show significant growth potential in terms of application, sample type, and geographical distribution?
• What was the past market performance of direct-to-consumer laboratory testing in the United States?
• What are the projected market trends and estimations for the duration spanning from 2023 to 2030?
• What are the primary factors propelling growth, hindering progress, presenting opportunities, and posing challenges in the U.S. direct-to-consumer laboratory testing market?
• Who are the primary participants in the U.S. direct-to-consumer laboratory testing industry?
• What does the competitive scenario look like, and which companies lead the market in U.S. direct-to-consumer laboratory testing?
• What are the latest advancements or updates in the U.S. direct-to-consumer laboratory testing sector?
• What strategies do the key players in the U.S. direct-to-consumer laboratory testing market employ?
• What are the patterns observed in different geographic regions and which regions or countries show notable growth potential?
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research